Corporate Neuro-Surveillance Accountability.
1. Introduction
Corporate Neuro-Surveillance Accountability is an emerging area of corporate governance, constitutional law, employment law, data-protection law, bioethics and human-rights regulation. It concerns the legal responsibility of corporations that collect, monitor, analyse, interpret, store or commercially exploit information generated by the human nervous system and brain activity.
Neuro-surveillance involves the use of technologies capable of observing or measuring neurological and cognitive signals, including:
Electroencephalography (EEG) and brainwave monitoring.
Brain–computer interfaces (BCIs).
Neuroimaging and neural-signal analysis.
Wearable neurotechnology and cognitive-monitoring devices.
Emotion, attention, fatigue and stress detection systems.
AI-based cognitive profiling and behavioural prediction.
Neuromarketing and neurological consumer analytics.
The central legal question is:
To what extent can a corporation monitor, analyse or commercially exploit an individual's neurological activity without violating that person's privacy, autonomy, dignity, freedom of thought and fundamental rights?
Traditional corporate surveillance generally observes external conduct, such as movements, communications, productivity and internet usage. Neuro-surveillance potentially goes further by examining internal cognitive and neurological processes.
Consequently, corporate accountability must extend beyond conventional data protection to include protection against coercive cognitive monitoring, neurological discrimination, psychological manipulation and unauthorised exploitation of neural information.
An important qualification is that there is not yet a comprehensive, settled body of case law specifically establishing corporate liability for workplace brainwave surveillance. The following analysis therefore distinguishes directly relevant privacy and surveillance precedents from analogous cases that provide principles for future neurotechnology litigation.
2. Meaning and scope of corporate neuro-surveillance accountability
Corporate neuro-surveillance accountability refers to the legal obligation of companies, directors, technology providers, employers and data processors to ensure that neurological monitoring is lawful, necessary, proportionate, transparent, secure and consistent with human dignity.
It has five principal dimensions.
A. Neurological privacy
Corporations must protect information revealing brain activity, emotional responses, cognitive patterns, attention levels and neurological conditions.
B. Cognitive autonomy
Individuals must retain the freedom to think, form opinions, experience emotions and make decisions without unjustified corporate interference.
C. Informed consent
Employees and consumers must understand what neurological information is collected, why it is collected, how it is analysed and whether it is shared with third parties.
D. Non-discrimination
Companies must not use neurological information to disadvantage individuals because of cognitive differences, mental characteristics, disabilities or inferred psychological vulnerabilities.
E. Corporate responsibility
Boards and senior management must establish appropriate policies, independent oversight, cybersecurity safeguards, audit mechanisms and remedies for unlawful neuro-surveillance.
3. Constitutional foundations of neuro-surveillance accountability in India
A. Article 21 – Right to life, dignity and privacy
Article 21 of the Constitution of India protects life and personal liberty. Its interpretation extends beyond physical survival to include privacy, dignity, bodily integrity and personal autonomy.
Neuro-surveillance can interfere with Article 21 when a company:
Collects neurological information without meaningful consent.
Monitors employees' mental or cognitive processes.
Uses brain-related data to predict private behaviour.
Creates psychological profiles without adequate safeguards.
Uses neurological characteristics to determine employment opportunities.
Exposes highly personal neurological information to commercial exploitation.
The constitutional significance is that the human mind is not merely another source of commercial information.
B. Article 20(3) – Protection against self-incrimination
Article 20(3) protects an accused person against compelled self-incrimination.
Its relevance to corporate neuro-surveillance arises when employers or private investigators attempt to compel employees to undergo neurological tests, brain-based deception detection or cognitive assessments for disciplinary investigations.
However, Article 20(3) is specifically concerned with compelled testimonial evidence in criminal proceedings. It should not automatically be treated as a general prohibition on every private workplace neurological test.
C. Article 14 – Equality and non-arbitrariness
Neurological profiling may create discriminatory classifications based on:
Cognitive performance.
Emotional responses.
Neurological conditions.
Attention patterns.
Perceived psychological stability.
Predicted behavioural tendencies.
Where government action is involved, Article 14 directly constrains arbitrary discrimination. In private employment, statutory equality protections, disability law, employment law and applicable constitutional principles may provide additional avenues of protection.
D. Article 19 – Freedom of expression and thought
Article 19(1)(a) protects freedom of speech and expression.
Although neurological monitoring does not necessarily amount to a direct restriction on speech, it may create a chilling effect if employees believe their private thoughts, emotional reactions or intellectual preferences are being analysed by their employer.
The broader legal principle is that freedom of expression requires meaningful protection of the mental space in which opinions and beliefs are formed.
4. Major judicial precedents and case laws
The following cases provide the principal legal foundations for developing corporate neuro-surveillance accountability.
Case 1. Justice K.S. Puttaswamy (Retd.) v. Union of India, (2017) 10 SCC 1
Foundational Indian precedent
Court: Supreme Court of India
Year: 2017
Legal issue: Whether privacy constitutes a fundamental right under the Indian Constitution.
Judgment:
A nine-judge Constitution Bench unanimously recognised privacy as a constitutionally protected fundamental right under Article 21 and other freedoms in Part III.
The judgment recognised several dimensions of privacy, including:
Bodily privacy.
Informational privacy.
Decisional autonomy.
Personal dignity.
Mental integrity.
Individual self-determination.
The Court specifically recognised that the dangers to informational privacy can originate from non-state actors as well as the State.
Application to corporate neuro-surveillance:
This decision provides the constitutional foundation for challenging intrusive corporate neurological monitoring.
For example, suppose a company introduces an AI-powered headset that continuously records employees' brainwaves and evaluates their concentration, emotional responses and cognitive engagement.
An employee could argue that the collection and exploitation of such information interferes with informational privacy and mental autonomy.
The judgment's proportionality framework also provides an important analytical test:
Legality: Is there a valid legal basis?
Legitimate aim: Is the purpose legally legitimate?
Necessity and proportionality: Is the intrusion justified and appropriately limited?
Legal significance: Puttaswamy provides a constitutional foundation for protecting neurological information against unjustified corporate exploitation, although it did not directly decide a corporate neuro-surveillance dispute.
Indian Kanoon+2
Case 2. Selvi v. State of Karnataka, (2010) 7 SCC 263
Directly relevant to brain-based testing
Court: Supreme Court of India
Year: 2010
Legal issue: Whether involuntary administration of narcoanalysis, polygraph examinations and Brain Electrical Activation Profile (BEAP) tests violates constitutional protections.
Judgment:
The Supreme Court held that involuntary administration of these scientific techniques violates Article 20(3) and Article 21.
The Court emphasised the importance of personal liberty, mental privacy and protection against compelled extraction of testimonial information.
It also recognised the constitutional significance of mental privacy and the dangers associated with scientific techniques that attempt to obtain information from an individual's mind without consent.
Application to corporate neuro-surveillance:
Consider a company that requires employees to undergo brain-based testing to identify:
Concealed dissatisfaction with management.
Suspected dishonesty.
Potential workplace disloyalty.
Hidden intentions to resign.
Psychological resistance to corporate policies.
If such testing is involuntary and seeks testimonial information, the reasoning in Selvi becomes particularly relevant.
However, the distinction is important: Article 20(3) does not automatically apply to every private employer's assessment. Its direct application depends on the constitutional requirements concerning an accused person and testimonial compulsion.
Article 21 privacy and autonomy principles provide a broader foundation for examining coercive private neuro-surveillance.
Legal significance: This is one of India's most important precedents for the protection of mental privacy against involuntary scientific examination.
Indian Kanoon+1
Case 3. Bărbulescu v. Romania, Application No. 61496/08 (2017)
Court: European Court of Human Rights, Grand Chamber.
Legal issue: Whether an employer's monitoring of an employee's electronic communications violated the right to privacy under Article 8 of the European Convention on Human Rights.
Judgment:
The Court found that Romania had failed to adequately protect the employee's right to privacy and correspondence.
It identified important considerations for workplace monitoring:
Whether advance notification was provided.
The extent of monitoring.
The reasons justifying surveillance.
Whether less intrusive alternatives were available.
The consequences for the employee.
Whether appropriate safeguards existed.
Application to neuro-surveillance:
If an employer monitors brain activity through wearable devices, the same proportionality considerations become relevant, potentially with greater intensity because neurological information can reveal intimate aspects of personal identity.
A general statement that employees are monitored is not necessarily adequate notice of continuous brainwave collection, emotional inference or psychological profiling.
Legal significance: Establishes a framework for evaluating workplace surveillance that can be adapted to neurological monitoring.
Bailii+2
Case 4. López Ribalda and Others v. Spain, Applications Nos. 1874/13 and 8567/13 (2019)
Court: European Court of Human Rights, Grand Chamber.
Legal issue: Whether covert workplace video-surveillance violated employees' privacy rights.
Judgment:
The Grand Chamber examined whether covert surveillance was justified in the circumstances, considering the employer's legitimate interests and the safeguards available to employees.
The Court discussed:
The justification for monitoring.
The scope and duration of surveillance.
The level of intrusion.
The number of individuals with access to collected information.
Whether less intrusive alternatives existed.
The safeguards available against misuse.
Application to neuro-surveillance:
An employer cannot assume that technological convenience automatically justifies neurological monitoring.
For example, monitoring an entire workforce through continuous EEG devices to identify possible productivity losses raises substantially different concerns from narrowly targeted monitoring for a documented safety risk.
Legal significance: Provides a useful proportionality framework for corporate surveillance, although it concerns video-surveillance rather than neural data.
Bailii+1
Case 5. Girardi v. Emotiv Inc., Rol No. 105.065-2023, judgment dated 9 August 2023
Landmark neurotechnology precedent
Court: Supreme Court of Chile.
Legal issue: Whether the commercialisation and processing of brain-related information through a neurotechnology device violated constitutional protections.
Background:
The dispute involved Guido Girardi's purchase of an Emotiv Insight neurotechnology device.
The device was capable of recording brain activity through EEG technology. Concerns arose about the storage, processing and protection of neurological information.
Judgment:
The Chilean Supreme Court accepted the constitutional protection claim and reversed the lower court's decision.
The case involved constitutional guarantees concerning:
Physical and psychological integrity.
Privacy.
Personal data protection.
Neurological information.
Application to corporate neuro-surveillance:
This case is especially important because it moves beyond conventional digital privacy and addresses the legal risks associated with commercial neurotechnology.
It demonstrates the significance of treating brain-generated information as particularly sensitive information requiring meaningful legal protection.
Legal significance: It is a major judicial precedent for the development of neuro-rights and corporate accountability concerning commercial brain-data technologies.
CORTE SUPREMA DE CHILE+1
5. Indian statutory framework governing corporate neuro-surveillance
A. Digital Personal Data Protection Act, 2023
The Digital Personal Data Protection Act, 2023 is particularly relevant where neurological information qualifies as digital personal data relating to an identifiable individual.
Its application may cover corporations collecting or processing:
Identifiable EEG recordings.
Digital brainwave patterns.
Neurological performance measurements.
AI-generated cognitive profiles.
Identifiable emotional and behavioural inferences.
Important statutory obligations include:
| Provision | Relevance to neuro-surveillance |
|---|---|
| Section 4 | Lawful processing of personal data |
| Section 5 | Notice requirements |
| Section 6 | Consent requirements |
| Section 7 | Certain legitimate uses |
| Section 8 | Obligations of data fiduciaries |
| Section 11 | Right to access information |
| Section 12 | Correction, completion, updating and erasure |
| Section 13 | Grievance redressal |
| Section 17 | Certain exemptions |
| Section 33 | Penalties for specified contraventions |
A company acting as a Data Fiduciary must comply with the applicable statutory requirements concerning lawful processing, transparency, security and individual rights.
Important distinction: The Act does not establish a separate statutory category called neural data or provide a special neuro-rights regime. Identifiable neurological data can nevertheless fall within its general definition of personal data.
The Digital Personal Data Protection Rules, 2025 were notified on 14 November 2025, providing the implementing framework for the legislation.
Press Information Bureau+1
B. Information Technology Act, 2000
The Information Technology Act, 2000 is relevant to corporate neuro-surveillance where electronic systems are involved.
Important provisions include:
Section 43: Addresses unauthorised access and specified forms of damage involving computer systems and data.
Section 66: Provides criminal consequences for specified acts under Section 43 when committed dishonestly or fraudulently.
Section 72: Addresses breach of confidentiality and privacy by persons obtaining access to information under powers conferred by the Act.
Section 72A: Addresses disclosure of personal information in breach of a lawful contract, with the required wrongful intent or knowledge.
These provisions may become relevant where neurological information is unlawfully accessed, disclosed or exploited, subject to their respective statutory ingredients.
C. Rights of Persons with Disabilities Act, 2016
The Rights of Persons with Disabilities Act, 2016 is relevant when corporate neuro-profiling disadvantages individuals because of disabilities.
For example:
Rejecting applicants because of neurological differences.
Excluding employees based on cognitive characteristics.
Using automated neurological scores as an employment eligibility test.
Failing to provide reasonable accommodation.
Section 3 prohibits discrimination against persons with disabilities, subject to the statutory framework and recognised exceptions.
Section 20 addresses non-discrimination in employment in government establishments.
The legislation provides an important foundation for challenging discriminatory neurological assessments.
D. Indian Contract Act, 1872
The Indian Contract Act, 1872 may become relevant when companies obtain consent through employment agreements, technology agreements or neurotechnology service contracts.
Potential legal issues include:
Coercive consent.
Undue influence.
Misrepresentation.
Unconscionable contractual terms.
Breach of contractual confidentiality.
Unauthorised secondary use of collected information.
An employee's signature on a general workplace monitoring agreement should not automatically be treated as unlimited permission to extract and commercially exploit neurological information.
6. Core doctrines of corporate neuro-surveillance accountability
6.1 Doctrine of neurological informational privacy
This doctrine recognises that information generated through neurological activity may reveal highly intimate aspects of an individual's personality.
Such information can potentially disclose:
Cognitive patterns.
Emotional reactions.
Attention fluctuations.
Certain neurological conditions.
Responses to particular stimuli.
Inferred psychological characteristics.
Corporate access to this information creates risks that extend beyond ordinary personal-data collection.
The doctrine can be developed through the privacy principles in Puttaswamy and the neurotechnology reasoning in Girardi v. Emotiv Inc.
6.2 Doctrine of cognitive autonomy
Cognitive autonomy protects the individual's capacity to think, reason, evaluate information and make independent decisions.
A corporation should not use neurological technology to manipulate employees' decision-making processes or impose intrusive monitoring of their private mental activities.
For example, an employer using neural feedback systems to identify workers who privately disagree with management could raise serious questions of autonomy and privacy.
6.3 Doctrine of meaningful neurological consent
Consent must be informed, specific and obtained through a legally valid process.
A meaningful consent framework should disclose:
What neurological signals are collected.
Whether raw brainwave recordings are retained.
Whether AI models infer emotions or cognitive states.
Whether information is shared with third parties.
Whether the data is used for employment decisions.
How long the information is retained.
How individuals can exercise their applicable legal rights.
Consent obtained through employment pressure requires particular scrutiny.
6.4 Doctrine of neural-data purpose limitation
A company collecting neurological data for workplace safety should not automatically be entitled to use the same information for employee ranking, disciplinary decisions, advertising or psychological profiling.
The original purpose and subsequent processing must comply with applicable legal requirements.
6.5 Doctrine of neurological non-discrimination
Companies should not make unjustified employment, insurance, promotion or consumer decisions based on inferred neurological characteristics.
For example, an AI system might classify an employee as having low emotional resilience because of particular neural responses.
Such an inference may be scientifically unreliable and legally problematic, especially if it leads to adverse employment treatment.
6.6 Doctrine of algorithmic neuro-transparency
Companies deploying AI-based neurotechnology should be capable of explaining:
The categories of neural data collected.
The analytical models employed.
The limitations of neurological inference.
The decision-making consequences.
The possibility of erroneous classification.
The procedures for human review and correction.
A corporation should not escape responsibility merely because a third-party algorithm generated the neurological assessment.
7. Forms of corporate liability
Corporate neuro-surveillance can generate several different forms of legal responsibility.
| Liability category | Possible corporate misconduct |
|---|---|
| Constitutional and public-law accountability | Unlawful conduct attributable to the State or public authorities |
| Data-protection liability | Unlawful collection or processing of identifiable neural data |
| Contractual liability | Breach of confidentiality or contractual obligations |
| Employment liability | Coercive monitoring or discriminatory employment decisions |
| Civil liability | Compensable harm resulting from wrongful conduct |
| Criminal liability | Offences committed by responsible persons where statutory requirements are satisfied |
| Regulatory liability | Failure to meet applicable cybersecurity, data-protection or sectoral requirements |
A private corporation is not automatically subject to every constitutional prohibition in the same way as the State. Nevertheless, constitutional rights may influence statutory interpretation, private-law duties and the State's positive obligations to protect individuals from private interference.
8. Corporate directors' duties and board accountability
Neuro-surveillance should be treated as a board-level governance issue rather than merely an IT-management matter.
Under the Companies Act, 2013, several provisions may become relevant.
Section 166 – Duties of directors
Directors must act in accordance with the company's articles, in good faith, and in the interests of the company and relevant stakeholders. They must exercise due and reasonable care, skill and diligence and independent judgment.
Section 134 – Corporate governance and board reporting
The Board's reporting and internal-control responsibilities may become relevant to the management of material privacy, technology and compliance risks.
Section 149 – Board composition and independent directors
Independent directors can contribute to scrutiny of technology-related risks, corporate ethics and compliance systems, within their statutory responsibilities.
Section 177 – Audit Committee
Where applicable, the Audit Committee can examine internal financial controls, risk-management systems and relevant compliance failures associated with neurotechnology.
A responsible board should establish:
A neurotechnology risk-management policy.
Independent privacy and ethical oversight.
Neurological data access controls.
Regular algorithmic audits.
Employee consultation mechanisms.
Vendor due diligence.
Incident-response procedures.
Clear restrictions on secondary use of neural data.
9. Corporate misconduct scenarios and legal consequences
Scenario 1: Compulsory brainwave monitoring
High privacy risk
An employer requires every employee to wear EEG headsets throughout working hours and records brain activity without providing adequate information or a legally valid basis.
Potential legal issues: Article 21 principles, DPDP Act obligations, employment law and consent validity.
Scenario 2: Neurological employee profiling
An AI system classifies workers according to emotional stability, concentration and predicted loyalty.
Potential legal issues: Privacy, fairness, accuracy, discrimination and procedural fairness.
Scenario 3: Commercial sale of brain data
A neurotechnology company transfers identifiable neural information to advertising companies without satisfying applicable legal requirements.
Potential legal issues: Data protection, contractual obligations, confidentiality and potentially civil or regulatory liability.
Scenario 4: Neurotechnology-based employee dismissal
A company dismisses an employee because a neural analytics system predicts low commitment or dissatisfaction.
Potential legal issues: Unfair employment practices, reliability of evidence, discrimination and procedural fairness.
Scenario 5: Neural-data security breach
A corporation suffers a cybersecurity incident exposing employees' identifiable brainwave recordings.
Potential legal issues: Data security obligations, applicable breach-notification requirements, regulatory penalties and possible civil claims.
10. International human-rights framework
Corporate neuro-surveillance accountability is also connected with international human-rights principles.
A. Universal Declaration of Human Rights, 1948
Article 1: Human dignity and equality.
Article 12: Protection against arbitrary interference with privacy.
Article 18: Freedom of thought, conscience and religion.
Article 19: Freedom of opinion and expression.
B. International Covenant on Civil and Political Rights, 1966
Article 17: Protection against arbitrary or unlawful interference with privacy.
Article 18: Freedom of thought, conscience and religion.
Article 19: Freedom of expression.
These provisions provide an international framework for evaluating the implications of corporate neuro-surveillance and the State's responsibility to protect individuals.
C. OECD principles on responsible innovation
The OECD framework for responsible innovation provides relevant guidance concerning human rights, accountability, transparency, security and responsible technology development.
Its principles can inform corporate neurotechnology governance, although they do not independently create a universal cause of action for neurological privacy violations.
11. Proposed Corporate Neuro-Surveillance Accountability Framework
A comprehensive corporate governance framework should incorporate the following ten safeguards.
| Governance mechanism | Corporate obligation |
|---|---|
| 1. Neural-data inventory | Identify all neurological information collected |
| 2. Consent management | Obtain legally valid and meaningful consent |
| 3. Purpose limitation | Restrict processing to lawful, specified purposes |
| 4. Data minimisation | Collect only information genuinely required |
| 5. Neurosecurity | Protect neural information against unauthorised access |
| 6. Algorithmic accountability | Audit AI-based neurological assessments |
| 7. Anti-discrimination | Prevent unjustified neurological profiling |
| 8. Independent oversight | Establish appropriate compliance supervision |
| 9. Individual remedies | Provide accessible grievance mechanisms |
| 10. Corporate reporting | Document significant neurological privacy risks |
A particularly important safeguard is the prohibition of covert neurological monitoring for employee loyalty testing, private thought assessment or psychological manipulation without a legitimate and legally sufficient justification.
12. Important unresolved legal questions
The development of corporate neuro-surveillance law raises several questions that courts and legislatures will increasingly need to address:
Should neural data receive a higher degree of legal protection than ordinary personal data?
Can employers require employees to use brain–computer interfaces?
Can an employee refuse neurological monitoring without suffering employment consequences?
Should corporations be prohibited from predicting employee loyalty through brainwave analysis?
Can neural data be used to determine insurance premiums?
Should AI-generated neurological inferences be treated as sensitive evidence?
Who is legally responsible when a third-party neurotechnology provider makes an inaccurate assessment?
Should corporate directors face additional governance duties concerning neurological privacy?
Can individuals demand deletion of identifiable neurological recordings and derived profiles under applicable law?
Should legislation establish an independent regulatory framework for commercial neurotechnology?
These questions demonstrate the need to develop a distinct legal framework for neural privacy and cognitive autonomy.
13. Critical legal analysis
The most significant challenge is the difference between traditional data surveillance and neurological surveillance.
Traditional corporate monitoring primarily examines observable behaviour. Neuro-surveillance can potentially generate information about the internal processes underlying that behaviour.
This creates three fundamental legal concerns.
First: The commodification of the human mind.
Commercial corporations may increasingly treat neurological information as an economic asset. This creates a risk that intimate cognitive characteristics become resources for commercial exploitation.
Second: The transformation of employment relationships.
The introduction of neurological monitoring could transform employers' supervisory powers into intrusive forms of cognitive assessment. This creates questions about the limits of managerial authority and the preservation of employee dignity.
Third: The expansion of algorithmic corporate power.
AI systems may make employment or commercial decisions using neurological inferences that individuals cannot independently verify. This raises concerns about accountability, transparency, scientific reliability and procedural fairness.
The law must therefore distinguish between legitimate, carefully regulated neurological applications and intrusive corporate practices that undermine individual autonomy.
14. Conclusion
Corporate Neuro-Surveillance Accountability represents an emerging field at the intersection of constitutional law, corporate governance, employment law, data protection and neuroethics.
The Indian constitutional foundation is particularly significant because K.S. Puttaswamy recognises privacy, informational autonomy and mental integrity, while Selvi v. State of Karnataka establishes important protections against involuntary scientific examination of the mind.
Internationally, Bărbulescu v. Romania and López Ribalda v. Spain provide principles for assessing workplace surveillance. Most directly, Girardi v. Emotiv Inc. demonstrates how courts can apply constitutional protections to commercial neurotechnology and brain-related information.
The central proposition of this emerging legal doctrine is:
Corporate ownership of technology does not confer ownership of the human mind. The capacity to measure neurological activity does not create an unrestricted legal entitlement to access, interpret, manipulate or commercialise an individual's cognitive processes.
The future development of corporate law should recognise neurological privacy, cognitive autonomy, meaningful consent and algorithmic accountability as essential components of responsible corporate governance.
15. Key case-law reference list
| Case | Principal legal contribution |
|---|---|
| K.S. Puttaswamy v. Union of India (2017) 10 SCC 1 | Constitutional privacy and informational autonomy |
| Selvi v. State of Karnataka (2010) 7 SCC 263 | Mental privacy and involuntary neurological testing |
| Bărbulescu v. Romania (2017) | Employee privacy and electronic monitoring |
| López Ribalda v. Spain (2019) | Proportionality of workplace surveillance |
| Girardi v. Emotiv Inc. (2023), Rol 105.065-2023 | Commercial neurotechnology and brain-data protection |
Academic research classification: This topic can be developed as a distinct doctoral-level research area under Corporate Law, Neuro-Rights, Constitutional Privacy and Algorithmic Governance. Its central contribution would be the development of a framework for assigning corporate responsibility for the collection, interpretation, manipulation and commercial exploitation of human neurological information.
Legal qualification: The cases above establish related legal principles, not a universal judicially recognised tort or standalone offence called corporate neuro-surveillance. Any actual claim must be established under the applicable constitutional, statutory and private-law provisions.

comments